📣 VC round data is live. Check it out!

Forian Valuation Multiples

Discover Forian's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Health In Tech, JLK, Susmed, SMAIO and more.

Forian Overview

About Forian

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.


Founded

2014

HQ

United States

Employees

48

Website

forian.com

Financials (FY)

Revenue: -
Net Income: -

EV

$36M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Forian Stock Performance

Forian has current market cap of $68M, and enterprise value of $36M.

Market Cap Evolution


Forian's stock price is $2.17.

Forian share price increased by 10.7% in the last year.

See more trading valuation data for Forian
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$36M$68M0.0%-4.9%10.7%-

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Forian Valuation Multiples

Forian Financial Valuation Multiples

As of June 3, 2026, Forian has market cap of $68M and EV of $36M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Forian Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Forian Competitors

Forian competitors include Health In Tech, JLK, Susmed, SMAIO, Research Solutions, ezCaretech, Omda, DocCheck, PharmX Technologies and Mach7 Technologies.

Most Forian public comparables operate across Healthcare Software, B2B SaaS, Vertical SaaS, ViceTech, CannaTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Health In Tech1.8x1.5x14.7x45.0x
JLK28.0x-(8.2x)-
Susmed12.7x12.7x(21.8x)-
SMAIO5.8x5.1x(60.2x)(63.8x)
Research Solutions1.2x1.3x11.5x10.2x
ezCaretech1.3x-20.7x-
Omda2.3x2.3x8.4x9.1x
DocCheck0.9x-5.0x-

This data is available for Pro users. Sign up to see all Forian competitors and their valuation data.

Start Free Trial

Acquisitions by Forian

Forian has acquired 1 company to date.

Last acquisition by Forian was on November 1st 2024. Forian acquired Kyber Data Science for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Forian

Kyber Data Science
Description
Kyber Data Science is a New York-based subsidiary of Cowen Inc. that curates proprietary datasets for institutional investors and hedge funds in equities, fixed income, and alternatives. The platform delivers granular data on corporate events, insider transactions, and supply chain metrics, serving clients like Citadel and Millennium Management. Acquired by Cowen in 2020, Kyber processes over 10 million data points daily from public filings, news wires, and satellite imagery to power quantitative trading strategies. Its tools integrate via APIs for seamless workflow embedding in buy-side research platforms.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date1 Nov 2024
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Forian acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Forian

When was Forian founded?Forian was founded in 2014.
Where is Forian headquartered?Forian is headquartered in United States.
How many employees does Forian have?As of today, Forian has over 48 employees.
Who is the CEO of Forian?Forian's CEO is Max C. Wygod.
Is Forian publicly listed?Yes, Forian is a public company listed on Nasdaq.
What is the stock symbol of Forian?Forian trades under FORA ticker.
When did Forian go public?Forian went public in 2021.
Who are competitors of Forian?Forian main competitors include Health In Tech, JLK, Susmed, SMAIO, Research Solutions, ezCaretech, Omda, DocCheck, PharmX Technologies, Mach7 Technologies.
What is the current market cap of Forian?Forian's current market cap is $68M.
Is Forian profitable?No, Forian is not profitable.
How many companies Forian has acquired to date?As of June 2026, Forian has acquired 1 company.
What was the largest acquisition by Forian?None of the M&A deals Forian has completed have disclosed valuations.
What companies Forian acquired?Forian acquired Kyber Data Science.
In how many companies Forian has invested to date?Forian hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Forian

Lists including Forian

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial